ICU Logo

SeaStar Medical Holding Corporation (ICU) 

NASDAQ
Market Cap
$9.06M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
385 of 958
Rank in Industry
233 of 549

Largest Insider Buys in Sector

ICU Stock Price History Chart

ICU Stock Performance

About SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult …

Insider Activity of SeaStar Medical Holding Corporation

Over the last 12 months, insiders at SeaStar Medical Holding Corporation have bought $12,716 and sold $0 worth of SeaStar Medical Holding Corporation stock.

On average, over the past 5 years, insiders at SeaStar Medical Holding Corporation have bought $21,875 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Chung Kevin (Chief Medical Officer) — $12,716.

The last purchase of 4,250 shares for transaction amount of $8,458 was made by Chung Kevin (Chief Medical Officer) on 2024‑11‑18.

List of Insider Buy and Sell Transactions, SeaStar Medical Holding Corporation

2024-11-18PurchaseChief Medical Officer
4,250
0.0842%
$1.99$8,458+6.53%
2024-09-30PurchaseChief Medical Officer
1,000
0.025%
$4.26$4,258-39.67%
2023-11-22Purchasedirector
100,000
0.5274%
$0.40$40,000+11.90%
2023-05-30PurchaseChief Medical Officer
12,543
0.17%
$0.47$5,953-1.70%
2022-04-05PurchaseChief Medical Officer
3,760
0.1986%
$1.85$6,956-38.29%

Insider Historical Profitability

<0.0001%
Chung KevinChief Medical Officer
13685
0.3066%
$2.0340<0.0001%
Van Heel Kennethdirector
116400
2.608%
$2.0310

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.